Cargando…

Unleashing nature's potential and limitations: Exploring molecular targeted pathways and safe alternatives for the treatment of multiple sclerosis (Review)

Driven by the limitations and obstacles of the available approaches and medications for multiple sclerosis (MS) that still cannot treat the disease, but only aid in accelerating the recovery from its attacks, the use of naturally occurring molecules as a potentially safe and effective treatment for...

Descripción completa

Detalles Bibliográficos
Autores principales: Fathallah, Sara, Abdellatif, Ahmed, Saadeldin, Mona Kamal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481116/
https://www.ncbi.nlm.nih.gov/pubmed/37680650
http://dx.doi.org/10.3892/mi.2023.102
_version_ 1785101904076865536
author Fathallah, Sara
Abdellatif, Ahmed
Saadeldin, Mona Kamal
author_facet Fathallah, Sara
Abdellatif, Ahmed
Saadeldin, Mona Kamal
author_sort Fathallah, Sara
collection PubMed
description Driven by the limitations and obstacles of the available approaches and medications for multiple sclerosis (MS) that still cannot treat the disease, but only aid in accelerating the recovery from its attacks, the use of naturally occurring molecules as a potentially safe and effective treatment for MS is being explored in model organisms. MS is a devastating disease involving the brain and spinal cord, and its symptoms vary widely. Multiple molecular pathways are involved in the pathogenesis of the disease. The present review showcases the recent advancements in harnessing nature's resources to combat MS. By deciphering the molecular pathways involved in the pathogenesis of the disease, a wealth of potential therapeutic agents is uncovered that may revolutionize the treatment of MS. Thus, a new hope can be envisioned in the future, aiming at paving the way toward identifying novel safe alternatives to improve the lives of patients with MS.
format Online
Article
Text
id pubmed-10481116
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-104811162023-09-07 Unleashing nature's potential and limitations: Exploring molecular targeted pathways and safe alternatives for the treatment of multiple sclerosis (Review) Fathallah, Sara Abdellatif, Ahmed Saadeldin, Mona Kamal Med Int (Lond) Review Driven by the limitations and obstacles of the available approaches and medications for multiple sclerosis (MS) that still cannot treat the disease, but only aid in accelerating the recovery from its attacks, the use of naturally occurring molecules as a potentially safe and effective treatment for MS is being explored in model organisms. MS is a devastating disease involving the brain and spinal cord, and its symptoms vary widely. Multiple molecular pathways are involved in the pathogenesis of the disease. The present review showcases the recent advancements in harnessing nature's resources to combat MS. By deciphering the molecular pathways involved in the pathogenesis of the disease, a wealth of potential therapeutic agents is uncovered that may revolutionize the treatment of MS. Thus, a new hope can be envisioned in the future, aiming at paving the way toward identifying novel safe alternatives to improve the lives of patients with MS. D.A. Spandidos 2023-08-17 /pmc/articles/PMC10481116/ /pubmed/37680650 http://dx.doi.org/10.3892/mi.2023.102 Text en Copyright: © Fathallah et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.
spellingShingle Review
Fathallah, Sara
Abdellatif, Ahmed
Saadeldin, Mona Kamal
Unleashing nature's potential and limitations: Exploring molecular targeted pathways and safe alternatives for the treatment of multiple sclerosis (Review)
title Unleashing nature's potential and limitations: Exploring molecular targeted pathways and safe alternatives for the treatment of multiple sclerosis (Review)
title_full Unleashing nature's potential and limitations: Exploring molecular targeted pathways and safe alternatives for the treatment of multiple sclerosis (Review)
title_fullStr Unleashing nature's potential and limitations: Exploring molecular targeted pathways and safe alternatives for the treatment of multiple sclerosis (Review)
title_full_unstemmed Unleashing nature's potential and limitations: Exploring molecular targeted pathways and safe alternatives for the treatment of multiple sclerosis (Review)
title_short Unleashing nature's potential and limitations: Exploring molecular targeted pathways and safe alternatives for the treatment of multiple sclerosis (Review)
title_sort unleashing nature's potential and limitations: exploring molecular targeted pathways and safe alternatives for the treatment of multiple sclerosis (review)
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481116/
https://www.ncbi.nlm.nih.gov/pubmed/37680650
http://dx.doi.org/10.3892/mi.2023.102
work_keys_str_mv AT fathallahsara unleashingnaturespotentialandlimitationsexploringmoleculartargetedpathwaysandsafealternativesforthetreatmentofmultiplesclerosisreview
AT abdellatifahmed unleashingnaturespotentialandlimitationsexploringmoleculartargetedpathwaysandsafealternativesforthetreatmentofmultiplesclerosisreview
AT saadeldinmonakamal unleashingnaturespotentialandlimitationsexploringmoleculartargetedpathwaysandsafealternativesforthetreatmentofmultiplesclerosisreview